RxDoctor Payments Data

Maggie Belton, DO

Family Medicine · Blacksburg, VANPI 1801023346

Payments from drug & device makers

$15,758in general payments, 2019–2025

Across 1,001 payments — averaging $15.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AbbVie$2K
  • AstraZeneca$1K
  • Pfizer$1K
  • Lilly USA, LLC$1K
  • Abbott$876
  • plus $7K from 48 others

What the payments were for

  • Food & beverage$15,746100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$15,758 in reported general payments places this provider in the 95th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$488,507
Medicare patients
912
Services billed
7,277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide330$439,239
JardianceEmpagliflozin168$175,443
EliquisApixaban113$120,128
MounjaroTirzepatide67$65,689
XareltoRivaroxaban46$64,933
FarxigaDapagliflozin Propanediol44$48,209
Tresiba Flextouch U-100Insulin Degludec44$32,976
Tresiba Flextouch U-200Insulin Degludec36$32,378
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$31,780
LinzessLinaclotide39$27,685
KerendiaFinerenone21$24,371
TrulicityDulaglutide15$22,666
Spiriva HandihalerTiotropium Bromide22$15,543
Synjardy XrEmpagliflozin/Metformin Hcl12$14,457
SynjardyEmpagliflozin/Metformin Hcl20$13,002

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$2,652$439,239330 claims
Boehringer IngelheimJardiance, Synjardy Xr, Synjardy, Stiolto Respimat$440$208,481212 claims
PfizerEliquis, Paxlovid$1,134$124,415137 claims
Lilly USA, LLCMounjaro, Trulicity$1,065$88,35582 claims
Johnson & JohnsonXarelto$288$64,93346 claims
AstraZenecaFarxiga, Symbicort$1,145$53,35265 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$257$48,14773 claims
AbbVieLinzess, Synthroid$1,615$33,517143 claims
BayerKerendia$617$24,37121 claims
Astellas Pharma US IncMyrbetriq$314$9,09218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Blacksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →